Clinuvel Pharmaceuticals Ltd.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLVLY and other ETFs, options, and stocks.

About CLVLY

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. 

CEO
Philippe Jacques Wolgen
CEOPhilippe Jacques Wolgen
Employees
Employees
Headquarters
Melbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded
1999
Founded1999
Employees
Employees

CLVLY Key Statistics

Market cap
351.89M
Market cap351.89M
Price-Earnings ratio
17.08
Price-Earnings ratio17.08
Dividend yield
0.37%
Dividend yield0.37%
Average volume
4.21K
Average volume4.21K
High today
$7.01
High today$7.01
Low today
$7.00
Low today$7.00
Open price
$7.00
Open price$7.00
Volume
1.00K
Volume1.00K
52 Week high
$9.00
52 Week high$9.00
52 Week low
$6.00
52 Week low$6.00

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.